Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to predict chronic pain in cancer patients

NCT ID NCT06511674

Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new tool called CANoPy that predicts whether a cancer patient will develop long-term nerve pain. Researchers will follow 625 adults with breast, gynecological, colorectal, or lung cancer as they undergo treatments like chemotherapy or surgery. By collecting questionnaire data on pain, emotions, and thinking, they hope to create a simple score that flags high-risk patients early, so doctors can tailor pain management from the start.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple way to predict which cancer patients are at high risk for chronic nerve pain, allowing earlier and more personalized pain treatment.
What could go wrong
This is an observational study, not a treatment trial. The tool may not prove accurate enough for routine use, and even if it works, it does not directly improve pain—it only identifies risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 625 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Patients: * Patient over 18 years of age, * Patient suffering from cancer (breast, gynecological, colorectal, lung) and having to undergo one or more anti-cancer therapeutic procedures (chemotherapy, surgery, hormonal therapy, radiotherapy, targeted therapy, etc.), * Sufficient cooperation and understanding to comply with the study requirements, * Agreement to give oral consent for the study, * Affiliation with the French Social Security system. Exclusion Criteria Patients: * History of cancer and anti-cancer therapy (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy, etc.), * History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma, etc.) ), * History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head trauma, etc.), * Medical and/or surgical history judged by the investigator or his representative to be incompatible with the study, * Subject whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol, * Pregnant or breast-feeding women, * Beneficiary of a legal protection measure. Inclusion Criteria Healthy Volunteers: * Subject over 18 years of age, * Subject free of any treatment in the 7 days preceding inclusion, in particular no use of analgesics, or judged by the investigator or his representative to be compatible with the study * Subject with no history of cancer, * Subject considered to be in good health by the investigator, * Sufficient cooperation and understanding to comply with the study requirements, * Agreement to give oral consent to the study, * Affiliation with the French Social Security system, Exclusion Criteria Healthy Volunteers: * Subjects with a medical and/or surgical history judged by the investigator or his representative to be incompatible with the trial, * Subjects whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol, * Pregnant or breast-feeding woman, * Participating in another clinical trial, or within the exclusion period, or having received a total amount of compensation exceeding 4500 euros over the 12 months preceding the start of the trial, * Benefiting from a legal protection measure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer cancer colorectal cancer female reproductive organ cancer lung cancer neoplasm neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Neuropathic pain Predictive

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Valenciennes

    RECRUITING

    Valenciennes, France

  • CHU de Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, 63000, France

  • Centre Hospitalier Henri Mondor d'Aurillac

    RECRUITING

    Aurillac, 15000, France

  • Centre Hospitalier Universitaire Caen Normandie

    RECRUITING

    Caen, 14000, France

  • Centre Hospitalier Yves Le Foll

    RECRUITING

    Saint-Brieuc, France

  • Centre Hospitalier d'Ajaccio

    RECRUITING

    Ajaccio, 20000, France

  • Centre Hospitalier de Montluçon

    NOT_YET_RECRUITING

    Montluçon, 03100, France

  • Centre Hospitalier de Moulins-Yzeure

    RECRUITING

    Moulins, 03000, France

  • Centre Régional de Lutte contre le Cancer - Georges Francois Leclerc

    RECRUITING

    Dijon, 21079, France

  • Centre de Lutte contre le Cancer - Centre François Baclesse

    RECRUITING

    Caen, 14000, France

  • Centre de Lutte contre le Cancer - Institut Bergonié

    RECRUITING

    Bordeaux, 33000, France

  • Centre de Lutte contre le Cancer - Institut de Cancérologie de l'Ouest

    RECRUITING

    Angers, 49100, France

  • Centre de Lutte contre le Cancer - Jean Perrin

    RECRUITING

    Clermont-Ferrand, 63000, France

  • Hôpital Beaujon AP-HP

    RECRUITING

    Paris, 92110, France

  • Hôpital Saint-Louis APHP

    RECRUITING

    Paris, 75010, France

  • Hôpital privé le Bois

    RECRUITING

    Lille, 59000, France

  • Hôpitaux civils de Colmar

    RECRUITING

    Colmar, 68024, France

  • Institut Godinot

    RECRUITING

    Reims, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.